For our advanced GC patients, although PD-L1 expression was less frequent in SRC than non-SRC, PD-L1 expression (35.5% vs. 12.5%, p = 0.003) was significantly higher in patients with peritoneal recurrence than in patients without peritoneal recurrence. Here, CD274 is linked to gastric cancer.